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Racemates as well as (R)- and (S)-enantiomers of 3-pivalamidoquinuclidine (PivQ) and 3-acet-
amidoquinuclidine (AcQ) were prepared. Their quaternary racemic and enantiomerically pure
N-benzyl derivatives (BnlPivQ and BnlAcQ) were synthesized as well. The amides were tested
as substrates and inhibitors of butyrylcholinesterase (BChE) from horse serum (EC 3.1.1.8).
No hydrolysis was observed under the experimental conditions applied. On the contrary, inhi-
bition of BChE by (R)- and (S)-enantiomers of N-benzylquinuclidinium amides of pivalic acid
was observed. The (S)-BnlPivQ with Ki = 41.57 µmol dm
–3 was 3-fold more potent inhibitor
than the (R)-enantiomer. On the other hand, preliminary results indicated that both enantiomers
of N-benzylquinuclidinum amides of acetic acid may possibly be inhibitors as well as activa-
tors depending on the concentrations of benzoylcholine (BzCh) used as a substrate of BChE.
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Quinuclidine compounds display a wide variety of bio-
logical activities. They have also been shown to be po-
tential antidotes against poisoning by organophosphorus
compounds such as pesticides and chemical warfare
agents.1 3-Substituted quinuclidines have been found es-
pecially interesting with respect to their pharmacological
properties. Several esters of quinuclidin-3-ol are even com-
mercially available as therapeutic agents.2 3-Amidoqui-
nuclidine derivatives are also classical 5-hydroxytrypt-
amine3 (5-HT3) receptor antagonists (since they contain
the generally recognized pharmacofore, i.e., basic nitro-
gen, carbonyl group and aromatic ring) such as e.g. za-
copride and RG 12915.3 Since 3-aminoquinuclidine con-
tains an asymmetric carbon atom, preparation of its ami-
des leads to racemates. Racemates of pharmaceuticals are
regarded with suspicion, since enantiomers of a given bio-
active compound can cause different biological effects,
ranging from lower activity of a less active enantiomer
to no response at all or even to increased toxicity.4 How-
ever, the resolution of 3-amidoquinuclidine derivatives to
pure enantiomers was shown to be difficult. Only few ex-
amples using chemical5–7 and biocatalytic8 methods have
been described so far.
In this paper, we report on the synthesis of (±)-, (R)-,
and (S)-3-pivalamidoquinuclidine derivatives and (±)-,
(R)-, and (S)-3-acetamidoquinuclidine. We also report on
the synthesis of their N-benzyl derivatives ((±)-, (R)-, (S)-
BnlPivQ and (±)-, (R)-, (S)-BnlAcQ) (Figure 1).
N-quaternary derivatives of 3-amidoquinuclidines
and esters of quinuclidin-3-ol may be looked upon as
bicyclic analogues of acethylcholine and benzoylcholine,
which are good substrates of BChE. Therefore, their in-
teraction with the enzyme could have been expected.
BChE was also found to be suitable as a biocatalyst for
the resolution of racemic quaternary quinuclidinium es-
ters.9–12 For these reasons, racemic nonquaternary and
quaternary quinuclidine amides were tested as possible
substrates primarily of BChE and then of some other hy-
drolytic enzymes. Under the experimental conditions de-
scribed in this work, no hydrolysis catalyzed by these en-
zymes occurred. But, N-benzyl derivatives of 3-amido-
quinuclidine were shown to inhibit BChE from horse se-
rum. To get more information on the inhibition mechanism
of that enzyme, the dissociation constants of the enzy-
me-inhibitor complexes were determined.
EXPERIMENTAL
Synthesis of Compounds
General Remarks. – Melting points were determined in open
capillaries using a Büchi B-540 apparatus and are uncorrect-
ed. Specific optical rotation values were determined on an
Optical Activity AA-10 automatic polarimeter at 589 nm in
methanol at ambient temperature (~ 24 °C). Elemental analy-
ses were performed with a Perkin-Elmer PE 2400 Series II
CHNS/O Analyzer. IR spectra were recorded with a Perkin-
Elmer FTIR 1725 X spectrometer. 1H and 13C 1D and 2D
NMR spectra were recorded on a Bruker AV300 and Bru-
ker AV600 spectrometer at ambient temperature. Chemical
shifts are given in ppm downfield from TMS as internal
standard. The (±)-, (R)- and (S)-3-aminoquinuclidine dihy-
drochlorides (Aldrich) were used for synthesis of the appro-
priate 3-amidoquinuclidines with pivalic and acetic acid an-
hydrides (Aldrich).
The (±)-, (R)- and (S)-3-aminoquinuclidine were prepar-
ed in high yields (>90 %) by treating commercial (±)-, (R)-
and (S)-3-aminoquinuclidine dihydrochlorides (200 mg,
1.00 mmol) with saturated aqueous solution of KOH (0.4 g,
7.13 mmol in 0.4 mL H2O). The aqueous reaction solution
was then extracted with chloroform (10 × 2 mL). The ex-
tracts were dried over K2CO3, filtered and evaporated under
reduced pressure. The samples were stored over CaCl2 un-
der reduced pressure.
Synthesis of Nonquaternary Derivatives
(±)-3-Aminoquinuclidine (0.126 g, 0.1 mmol) was added to
pivalic acid anhydride (246 mL, 1.20 mmol) in dry THF
(1 mL). The reaction mixture was heated under stirring over-
night at 70 °C. Water was added to the reaction mixture and
the pH value was fixed at ≈1 with conc. HCl, then extracted
with diethyl ether (4 × 10 mL). After extraction with diethyl
ether, the pH value of the water phase was fixed at ≈10 with
50 % aqueous solution of NaOH and extracted with chloro-
form (5 × 10 mL). Chloroform extracts were dried over
Na2SO4, filtered and evaporated under reduced pressure to
give:
(±)-3-(2,2-Dimetilpropanamido)quinuclidine ((±)-PivQ). –
Obtained as white crystals; 188 mg (90 %); m.p. 132.2–
133.4 °C; IR (KBr) nmax/cm–1: 3369 (N–H), 2949 (C–H),
1635 (C=O), 1127 (C–N); 1H NMR (DMSO-d6) d/ppm:
1.11 (s, 9H, (CH3)3C), 1.21–1.26 (m, 1H, H-5), 1.44–1.56
(m, 2H, H-8), 1.65–1.72 (m, 2H, H-4 and H-5), 2.55–2.68
(m, 4H, H-6, H-7 and H-2), 2.81–2.85 (m, 1H, H-7),
2.94–2.99 (m, 1H, H-2), 3.65–3.68 (m, 1H, H-3), 7.14 (d,
J = 6.47 Hz, 1H, CONH); 13C NMR (DMSO-d6) d/ppm:
19.96 (C-5), 25.62 (C-4), 25.74 (C-8), 27.50 ((CH3)3C),
38.05 ((CH3)3C), 46.49 (C-6), 46.57 (C-3), 46.80 (C-7),
53.59 (C-2), 177.45 (C=O).
Anal. Calcd. for C12H22N2O (Mr = 210.32): C 68.53, H
10.54, N 13.32 %; found: C 68.22, H 10.19, N 12.96 %.
(R)-3-(2,2-Dimetilpropanamido)quinuclidine ((R)-PivQ). –
Obtained from (R)-3-aminoquinuclidine (0.126 g, 0.99 mmol)
and pivalic acid anhydride as white crystals; 188 mg (90 %);
m.p. 131.2–132.4 °C; [a]D
25 +29° (c = 1.01, MeOH).
(S)-3-(2,2-Dimetilpropanamido)quinuclidine ((S)-PivQ). –
Obtained from (S)-3-aminoquinuclidine (0.125 g, 0.99 mmol)
and pivalic acid anhydride as white crystals; 192 mg (92 %);
m.p. 132.5–133.5 °C; [a]D
25 –30° (c = 1.02, MeOH).
The mixture of (±)-3-aminoquinuclidine (0.300 g, 2.40
mmol) and acetic acid anhydride (1.12 mL, 11.9 mmol) was
refluxed for 3 hours. Distillation under reduced pressure was
used to remove the excess of acetic acid anhydride. The re-
sidue upon distillation was neutralized with saturated aqueous
solution of K2CO3 (5 mL) and extracted with chloroform
(5 × 10 mL). The extracts were dried over Na2SO4, filtered
and evaporated under reduced pressure. The obtained black
oil was distilled under reduced pressure of 0.01 mmHg to
give:
(±)-3-Acetamidoquinuclidine ((±)-AcQ). – Obtained as
white crystals; 374 mg (93 %); m.p. 120–122 °C; IR (KBr)
nmax/cm–1: 3290 (N–H), 2949 (C–H), 1654 (C=O), 1132
(C–N); 1H NMR (DMSO-d6) d/ppm: 1.22–1.30 (m, 1H,
H-5), 1.41–1.60 (m, 2H, H-8), 1.67–1.75 (m, 2H, H-4 and
H-5), 1.81 (s, 3H, CH3), 2.34–2.40 (dd, J = 4.67 Hz; J =
13.44 Hz, 1H, H-2), 2.46–2.79 (m, 4H, H-6 and H-7),
2.97–3.06 (m, 1H, H-2), 3.66–3.71 (m, 1H, H-3), 7.88 (d, J
= 6.46 Hz, 1H, CONH); 13C NMR (DMSO-d6) d/ppm:
19.87 (C-5), 22.67 (C-4), 25.66 (C-8), 25.71 (CH3), 46.11
(C-3), 46.28 (C-6), 46.92 (C-7), 54.58 (C-2), 168.98
(C=O).
Anal. Calcd. for C9H16N2O (Mr = 168.24): C 64.25, H
9.59, N 16.65 %; found: C 64.05, H 9.24, N 16.32 %.
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Figure 1. Structures of quinuclidine derivatives.
(R)-3-Acetamidoquinuclidine ((R)-AcQ). – Obtained from
(R)-3-aminoquinuclidine (0.100 g, 0.79 mmol) and acetic
acid anhydride as white crystals; 123 mg (84 %); m.p.
134.5–135.6 °C; [a]D
25 +37° (c = 1.01, MeOH).
(S)-3-Acetamidoquinuclidine ((S)-AcQ). – Obtained from
(S)-3-aminoquinuclidine (0.120 g, 0.95 mmol) and acetic
acid anhydride as white crystals; 156 mg (89 %); m.p. 125.9–
127 °C; [a]D
25 –35° (c = 0.98, MeOH).
Synthesis of N-quaternary Derivatives
To the solution of the appropriate 3-amidoquinuclidine
((±)-PivQ, 0.050 g, 0.43 mmol or (±)-AcQ, 0.470 g, 2.6
mmol) in dry acetone (1 mL), equimolar amounts of benzyl
bromide were added under stirring at room temperature.
The reaction mixture was kept in the dark overnight to ob-
tain a solid. Recrystallization from acetonitrile gave:
(±)-N-benzyl-3-(2,2)-dimetilpropanamidoqinuclidinium bro-
mide ((±)-BnlPivQ). – Obtained as white crystals; 78 mg
(86 %); m.p. 166–167 °C; IR (KBr) nmax/cm–1: 3231
(N–H), 2962 (C–H), 1652 (C=O), 1527 (C=C), 1063
(C–N); 1H NMR (DMSO-d6) d/ppm: 1.11 (s, 9H,
((CH3)3C), 1.70–1.80 (m, 2H, H-5), 1.87–1.97 (m, 2H,
H-8), 2.02–2.08 (m, 1H, H-4), 3.25–3.50 (m, 5H, H-2, H-6
and H-7), 3.76–3.83 (m, 1H, H-2), 4.07–4.15 (m, 1H, H-3),
4.46 (s, 2H, CH2 Bnl), 7.52 (s, 5H, Bnl), 7.62 (d, J = 5.52
Hz, 1H, CONH); 13C NMR (DMSO-d6) d/ppm: 18.24
(C-5), 22.14 (C-8), 24.74 (C-4), 27.24 ((CH3)3C), 38.01
((CH3)3C), 44.88 (C-3), 53.27 (C-6), 53.43 (C-7), 58.36
(C-2), 66.31 (CH2 Bnl), 127.45 (C-1 Bnl), 128.95 (C-3 Bnl
and C-5 Bnl), 130.15 (C-4 Bnl), 133.05 (C-2 Bnl and C-6
Bnl), 177.96 (C=O).
Anal. Calcd. for C19H29BrN2O (Mr = 381.35): C 59.84,
H 7.66, N 7.35 %; found: C 59.93, H 7.58, N 7.15 %.
(R)-N-benzyl-3-(2,2)-dimetilpropanamidoqinuclidinium bro-
mide ((R)-BnlPivQ). – Obtained from (R)-3-(2,2-dimetil-
propanamido)quinuclidine (0.088 g, 0.42 mmol) and benzyl
bromide as white crystals, 157 mg (98 %); m.p. 123.5–
125 °C; [a]D
25 +21° (c = 1.0, MeOH).
(S)-N-Benzyl-3-(2,2)-dimetilpropanamidoqinuclidinium bro-
mide ((S)-BnlPivQ). – Obtained from (S)-3-(2,2-dimetil-
propanamido)quinuclidine (0.092 g, 0.44 mmol) and benzyl
bromide as white crystals, 156 mg (93 %); m.p. 135.5–
137 °C; [a]D
25 –21° (c = 1.02, MeOH).
(±)-N-benzyl-3-acetamidoqinuclidinium bromide ((±)-BnlAcQ).
– Obtained as white crystals; 813 mg (90 %); m.p. 218–
218.5 °C; IR (KBr) nmax/cm–1: 3218 (N–H), 2953 (C–H), 1664
(C=O), 1523 (C=C), 1151 (C–N); 1H NMR (DMSO-d6)
d/ppm: 1.77–1.87 (m, 3H, H-4 and H-8), 1.94–2.01 (m, 3H,
CH3), 2.95–2.97 (m, 1H, H-2), 3.27–3.38 (m, 6H, H-5, H-6
and H-7), 3.72–3.76 (m, 1H, H-2), 4.02–4.04 (m, 1H, H-3),
4.39 (s, 2H, CH2 Bnl), 7.43–7.47 (m, 5H, Bnl), 8.24 (d, J =
6.13 Hz, 1H, CONH); 13C NMR (DMSO-d6) d/ppm: 18.21
(C-5), 22.25 (C-8), 22.34 (C-4), 24.59 (CH3), 44.41 (C-3),
53.32 (C-6), 53.35 (C-7), 59.53 (C-2), 66.30 (CH2 Bnl),
127.37 (C-1 Bnl), 128.94 (C-3 Bnl and C-5 Bnl), 130.16
(C-4 Bnl), 133.01 (C-2 Bnl and C-6 Bnl), 169.58 (C=O).
Anal. Calcd. for C16H23BrN2O (Mr = 339.27): C 56.46,
H 6.83, N 8.26 %; found: C 56.65, H 6.72, N 8.37 %.
(R)-N-benzyl-3-acetamidoqinuclidinium bromide ((R)-BnlAcQ).
– Obtained from (R)-3-acetamidoquinuclidine (0.050 g,
0.272 mmol) and benzyl bromide as white crystals; 83 mg
(86 %); m.p. 203–206 °C; [a]D
25 +37° (c = 1.0, MeOH).
(S)-N-benzyl-3-acetamidoqinuclidinium bromide ((S)-BnlAcQ).
– Obtained from (S)-3-acetamidoquinuclidine (0.080 g,
0.434 mmol) and benzyl bromide as white crystals; 111 mg
(72 %); m.p. 199.5–202 °C; [a]D
25 –35° (c = 1, MeOH).
Substrate Hydrolysis
For the hydrolysis of prepared racemic amides, butyrylcho-
linesterase from horse serum, BChE, (E.C. 3.1.1.8, lyophiliz-
ed, Sigma Chem. Co.) and a series of hydrolytic enzymes:
proteinase from bacillus subtilis, (EC 3.4.24.4, Fluka), a-
chymotrypsin from bovine pancreas (EC 3.4.21.1, Fluka),
esterase from porcine liver, PLE, (EC 3.1.1.1, Sigma),
lipase from hog pancreas, PPL, (EC 3.1.1.3, Fluka), lipase
from wheat germ, (EC 3.1.1.3, Sigma) and amidase from
human serum, (EC 3.5.1.28, N-acethylmuramyl-L-alanine
amidase) were tested as possible biocatalysts. Substrates
(±)-PivQ, (±)-AcQ, (±)-BnlPivQ and (±)-BnlAcQ (0.044
mmol) were dissolved in phosphate buffer (300 mL, 0.2 mol,
dm–3; Na2HPO4/NaH2PO4; pH = 7.4) in all reactions except
in that with the amidase. In the hydrolysis with amidase,
the substrates (0.044 mmol) were dissolved in Tris/HCl
buffer (300 mL, pH = 8) with MgCl2. The enzymes (3 mg
of each; 100 mL of the amidase) were then added. The re-
actions were carried out in a Heidolph UNIMAX 1010 shaker
at 30 °C. Reactions were followed by TLC on aluminium
oxide with CHCl3 : MeOH = 9 : 1 as eluent.
Enzyme Inhibition
Inhibition of the enzyme by enantiomers of N-benzyl-3-ami-
doquinuclidine derivatives was measured with benzoylcholine
chloride (BDH Chemicals Ltd.) as the substrate of BChE.
BChE (EC, 3.1.1.8), type IV-S, lyophilized from horse se-
rum (Sigma Chemical Co.) was used without further purifi-
cation. HPLC analyses (Thermo Separation Products, Spec-
tra SYSTEM 2000) were performed on an RP-18 column
(Waters, SymmetryShield, 5 mm, 150 × 3.9 mm i.d.) at 40 °C.
The mobile phase used was water-methanol-acetonitrile-ace-
tic acid-triethylamine (60 : 25 : 15 : 0.33 : 0.2) at a flow-rate
of 1.0 mL min–1. The reactions were carried out in a Hei-
dolph UNIMAX 1100 shaker at room temperature.
Interactions of N-quaternary quinuclidinamides, (R)-
BnlPivQ, (S)-BnlPivQ, (R)-BnlAcQ and (S)-BnlAcQ, with
BChE were monitored by following the production of ben-
zoic acid from benzoylcholine hydrolysis at 230 nm by a
UV detector (HPLC). All experiments were performed in a
total volume of 1.0 mL and an enzyme concentration of
1.5 nmol dm–3 (0.016 mg mL–1). The enzymatic reaction was
stopped by the addition of aliquots (20 µL) of the reaction
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mixture to the HPLC mobile phase (200 µL). Two to three
measurements were made with each substrate concentration
(0.1–0.5 mmol dm–3). The KM values were obtained by
non-linear regression of the experimental data to the Mi-
chaelis-Menten equation. The dissociation constant of the
enzyme-inhibitor complex was determined from the Hun-
ter-Downs plot, using 0.1–0.5 mmol dm–3 concentrations of
substrates.13
Enzyme-inhibitor Dissociation Constants
Reversible inhibition of BChE was measured for all enan-
tiomers of N-benzyl derivatives. Inhibition was determined
with benzoylcholine (BzCh) as a substrate of the enzyme.
To study the competition between N-benzyl-3-amidoquinu-
clidinium derivatives and the substrate, activities of the enzy-
mes were measured at different substrate concentrations [S]
in the absence (v0) and in the presence (vi) of a given inhi-
bitor concentration [I]. Concentrations of the inhibitor were
chosen to inhibit the enzyme between 20–80 %. For each
substrate concentration, the apparent dissociation constants
(Kapp) were calculated. The enzyme-inhibitor dissociation
constants (Ki) were evaluated from the Hunter-Downs equa-
tion using linear regression analysis13 where Kapp is the ap-
parent enzyme-inhibitor dissociation constant at a given
substrate concentration [S] and KM is the Michaelis con-















Synthesis of Quinuclidine Derivatives
3-Amidoquinuclidines, racemates as well as both enan-
tiomers were synthesized from the appropriate 3-amino-
quinuclidine with pivalic or acetic acid anhydrides. Ra-
cemic and enantiomerically pure 3-aminoquinuclidines
were obtained from the appropriate 3-aminoquinuclidine
dihydrochlorides (Scheme 1). N-Quaternary derivatives
of 3-amidoquinuclidine were synthesized by quaterniza-
tion of appropriate chiral amides with benzyl bromide
(Scheme 1).
Synthesized compounds were identified and charac-
terized by IR, one- and two-dimensional 1H and 13C NMR
spectroscopies, elemental analyses and by determining the
melting points and optical rotation values.
Hydrolysis of Derivatives of 3-amidoquinuclidines
One of the enzymes tested as a biocatalyst for the hydro-
lysis of synthesized racemic amides was butyrylcholine-
sterase (BChE, EC 3.1.1.8). BChE is a serine hydrolase
that has a structure similar to that of acetylcholinesterase.14
The active site of this enzyme consists of several major
domains: (i) esteratic site containing active serine as a part
of the catalytic triade (Ser-His-Glu); (ii) acyl pocket, a
hydrophobic region that accommodates the acyl group of
an ester or amide; (iii) choline subsite consisting of tryp-
tophan for molecular recognition of the substrate's quater-
nary ammonium group; and (iv) oxyanion hole, formed
by the main chain N–H dipoles interacting with the car-
bonyl oxygen of the substrate.
Although this enzyme has not been much investigat-
ed as a catalyst in organic synthesis, it was shown that it
could accept as substrates compounds with diverse struc-
tures such as e.g. some drugs like heroin, aspirin and
succinylcholine.15 In the case of quinuclidines, BChE has
been previously used for the hydrolysis of the racemic
quinuclidine-3-yl butyrate,9 quinuclidin-3-yl benzoates and
their N-methyl and N-benzyl derivatives.10,11 Quaternary
quinuclidinium benzoates were better substrates for BChE
than their nonquaternized analogues.10 This is not sur-
prising because N-quaternary derivatives of quinuclidine
esters and amides have structural similarities with BzCh
and acetylcholine, which are good substrates of BChE
(Figure 2).
We tested racemic 3-amidoquinuclidines as substra-
tes for the possible hydrolysis by BChE. The catalytic steps
in amides hydrolysis would involve initial formation of
an enzyme-substrate complex, followed by an acylation
step, and finally water would cause deacylation of the
enzyme.16 However, no hydrolysis was observed under
experimental conditions described in this work. The at-
tempts to achieve selective hydrolysis of racemic tertiary
104 R. OD@AK et al.
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Scheme 1.
and quaternary derivatives of 3-amidoquinuclidine cata-
lyzed by some other hydrolytic enzyme such as PPL and
lipase from wheat germ, PLE (an esterase), subtilisin and
chymotrypsin (proteases) and an amidase from human
serum,17 were unsuccessful.
Inhibition of BChE by
Quaternary-3-amidoquinuclidines Derivatives
Since it was shown earlier that the enantiomers of N-qua-
ternary quinuclidinium esters were good reversible in-
hibitors of BChE,10–12 it can be assumed that the enan-
tiomers of N-quaternary derivatives of 3-amidoquinucli-
dines act as reversible inhibitors of BChE as well. In our
previous work,18 N-quaternary 3-benzamido- and 3-bu-
tanamidoquinuclidinium compounds were tested as inhi-
bitors of BChE. The degree of inhibition was shown to
be dependant on the structure of the acyl group. We con-
firmed that the (S)-enantiomer of N-benzyl-3-benzami-
doquinuclidinium bromide was the most potent inhibitor
with Ki = 3.7 mmol dm–3. Therefore, we tested (R)-
BnlPivQ, (S)-BnlPivQ, (R)-BnlAcQ and (S)-BnlAcQ as
inhibitors of BChE with BzCh as the substrate.
The measured activity of BChE at different concen-
trations of BzCh showed that the Michaelis-Menten ki-
netics was followed in a given concentration area. The
value of KM of (0.16 ± 0.02) mmol dm–3 was obtained
from the Lineweaver-Burk plot (Figure 3) for BzCh as
the substrate of BChE. This value is in accord with pre-
viously published data.10
The measured activity of BChE at different concen-
trations of both enantiomers of quaternary 3-pivalamido-
quinuclidines (R)-BnlPivQ and (S)-BnlPivQ showed that
the Michaelis-Menten kinetics was followed as well.
The apparent increase of KM values which were obtained
from the Lineweaver-Burk plot was observed for both
enantiomers of quaternary 3-pivalamidoquinuclidines (Fig-
ure 3). This led to the assumption that these compounds
were competitive inhibitors, i.e., that they compete for
the same active site on the enzyme as does the substrate
(BzCh). In this case, in the Lineweaver-Burk plot, the
same ordinal intercept (1/v) is expected in the presence
or absence of the inhibitor. The kinetics of inhibition by
(R)-BnlPivQ indicated that this compound is a compe-
titive inhibitor and therefore binds to the catalytic site of
BChE. On the other hand, the (S)-BnlPivQ does not have
the same ordinal intercept as the substrate, which indica-
tes that this enantiomer may be a mixed noncompetitive
inhibitor that binds to both the enzyme and enzyme-sub-
strate forms of the enzyme (Figure 3). Further studies
would be necessary to determine the mechanism of ac-
tion of the (S)-BnlPivQ.
The Hunter-Downs plots of the reversible inhibition
of BChE by the quaternary enantiomers of 3-pivalami-
doquinuclidines (R)-BnlPivQ and (S)-BnlPivQ displayed
curves that indicated competition between the inhibitors
and BzCh. A linear relationship between the apparent
dissociation constants and the substrate concentration
between 0.1 and 0.5 mmol dm–3 was obtained for both
enantiomers (R)-BnlPivQ and (S)-BnlPivQ (Figure 4).
For these enantiomers, the enzyme-inhibitor dissociation
constant (Ki) was obtained, which indicated that both
enantiomers were good inhibitors of BChE. The more
potent inhibitor (with the lowest dissociation constant) was
the (S)-enantiomer with Ki = (41.57 ± 0.09) mmol dm–3
and it had 3-fold higher affinity for BChE than the (R)-
enantiomer.
The obtained inhibition constants for compounds
(R)-BnlPivQ and (S)-BnlPivQ are displayed in Table I.
The measured activity of BChE at different concen-
trations of both enantiomers of quaternary 3-acetamido-
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Figure 3. Lineweaver-Burk plot in the absence () and presence
of inhibitor (R)-BnlPivQ () and (S)-BnlPivQ (). Concentration of
(R)-enantiomer is 0.138 mmol dm–3 while that of (S)-enantiomer
is 0.666 mmol dm–3.
quinuclidines (R)-BnlAcQ and (S)-BnlAcQ showed that
the Michaelis-Menten kinetics was followed as well.
Preliminary results indicated that in the concentration
area of BzCh between 0.1 and 0.15 mmol dm–3 these
enantiomers may possibly act as inhibitors of BChE
while in the higher concentration area they may act as
possible activators of the enzyme (Figure 5). Therefore,
Ki and KM values for (R)-BnlAcQ and (S)-BnlAcQ could
not be determined.
CONCLUSIONS
We have synthesized racemic and enantiomerically pure
amides of 3-aminoquinuclidine with pivalic and acetic
acid anhydride. Their quaternary racemic and enantio-
merically pure N-benzyl derivatives were also prepared.
Nonquaternary and quaternary synthesized racemic ami-
des were tested as possible substrates of BChE and some
other hydrolytic enzymes. However, hydrolysis was not
observed. Enantiomerically pure quaternary derivatives
were then tested as inhibitors of BChE. Both enantio-
mers of N-benzyl-3-pivalamidoquinuclidines were good
inhibitors of BChE. However, preliminary experiments in-
dicate that both enantiomers of N-benzyl-3-acetamido-
quinuclidines may be inhibitors and activators of BChE
depending on the concentration of BzCh.
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SA@ETAK
Derivati 3-amidokinuklidina: Priprava i interakcija s butirilkolinesterazom
Renata Od`ak, Ines Primo`i~ i Sr|anka Tomi}
Pripravljeni su racemati te (R)- i (S)-enantiomeri 3-pivalamidokinuklidina (PivQ) i 3-acetamidokinuklidina
(AcQ). Tako|er su sintetizirani i njihovi N-benzilni derivati (BnlPivQ and BnlAcQ). Amidi su testirani kao
supstrati i inhibitori butirilkolinesteraze iz konjskog seruma (EC 3.1.1.8). Hidroliza nije uo~ena u opisanim
eksperimentalnim uvjetima. Uo~ena je, me|utim, inhibicija BChE sa (R)- i (S)-enantiomerima N-benzilkinukli-
dinijevih amida pivalinske kiseline. (S)-BnlPivQ s Ki = 41,57 µmol dm
–3 je 3 puta ja~i inhibitor u odnosu na
(R)-enantiomer. S druge strane, preliminarni rezultati ukazuju da su oba enantiomera N-benzilkinuklidinijevih
amida octene kiseline mogu}i inhibitori i aktivatori ovisno o koncentracijama benzoilkolina (BzCh) kao supstrata
BChE.
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